A multicentre, randomized, intraindividual comparative pharmacokinetic trial to evaluate the bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea

Trial Profile

A multicentre, randomized, intraindividual comparative pharmacokinetic trial to evaluate the bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Dec 2015

At a glance

  • Drugs Brimonidine (Primary) ; Brimonidine
  • Indications Erythema
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top